The overall survival rate ( P =0.0646), overall response rate ( P =0.410), and disease control rate ( P =0.396) were improved in the experimental group, but these changes did not reach statistical significance.
← all excerpts
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.
1
—
—